← Back to Search

CHOICE for Hyperglycemia

N/A
Waitlist Available
Led By Mary E. Jung, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Blood pressure of <160/99 mm Hg assessed according to Canadian Hypertension Education Program guidelines
BMI between 22-45 kg/m2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up sex months post-intervention while controlling for baseline values.
Awards & highlights

Study Summary

This trial will test if people with high blood sugar can lower their risk of chronic diseases by exercising, and if giving them a choice of exercises increases motivation and activity.

Eligible Conditions
  • Hyperglycemia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months post-intervention while controlling for baseline values.
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months post-intervention while controlling for baseline values. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Perceived Autonomy Support
Secondary outcome measures
Cardiorespiratory Fitness
Exercise Motivation Regulation
Physical Activity Behavior (Accelerometry)
+2 more
Other outcome measures
Exercise enjoyment
Exercise motivation
In-task affective responses

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: CHOICEExperimental Treatment1 Intervention
Participants will be introduced to HIIT and MICT during sessions 1 and 2 of the 4-week intervention in a counterbalanced randomized order, and will thereafter self-select one of the two exercise types for remaining sessions. Exercise will be matched to the parallel imposed conditions.
Group II: MICTActive Control1 Intervention
Continuous exercise for 30 minutes per session at 60-70% of heart rate max for five times per week, consistent with physical activity guidelines that advocate 150 minutes per week of moderate activity.
Group III: HIITActive Control1 Intervention
Five repeated vigorous intervals of 1-min duration at 80-90% of heart rate max interspersed with 1-min recovery periods; 3-min warm-up and 2-min cool-down, making the total session duration 15 minutes for five times/week, equated to match the guidelines of 75 min of vigorous exercise per week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CHOICE
2006
N/A
~200

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,472 Total Patients Enrolled
6 Trials studying Hyperglycemia
6,239 Patients Enrolled for Hyperglycemia
Heart and Stroke Foundation of CanadaOTHER
122 Previous Clinical Trials
72,132 Total Patients Enrolled
Mary E. Jung, PhDPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~23 spots leftby Mar 2025